Page last updated: 2024-08-22

buthionine sulfoximine and Lymphoma, Mantle-Cell

buthionine sulfoximine has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernstein, SH; Brookes, PS; Casulo, C; Dai, Y; Grant, S; Hilchey, SP; Kiebala, M; Maggirwar, SB; Peterson, DR; Skalska, J1

Other Studies

1 other study(ies) available for buthionine sulfoximine and Lymphoma, Mantle-Cell

ArticleYear
Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Experimental hematology, 2015, Volume: 43, Issue:2

    Topics: Antimetabolites; Antineoplastic Agents; Auranofin; B-Lymphocytes; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Lymphoma, Mantle-Cell; Molecular Targeted Therapy; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture; Signal Transduction; Thioredoxin-Disulfide Reductase; Thioredoxins

2015